UBS Initiates Coverage On Veracyte with Buy Rating, Announces Price Target of $43

Benzinga · 10/16 13:03
UBS analyst Lu Li initiates coverage on Veracyte (NASDAQ:VCYT) with a Buy rating and announces Price Target of $43.